RecruitingNot ApplicableNCT06984952

Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy

Effectiveness of Enhanced Recovery After Surgery (ERAS) on Postoperative Recovery After Minimally Invasive Gastrectomy: A Multi-center Open-labeled Randomized Controlled Study


Sponsor

Seoul National University Hospital

Enrollment

308 participants

Start Date

Jun 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective, randomized, open-label, multicenter study is designed to evaluate the impact of an enhanced recovery after surgery (ERAS) protocol on the rate of meeting discharge criteria in patients undergoing minimally-invasive gastrectomy for gastric cancer. We hypothesize that implementation of our ERAS protocol will significantly increase the proportion of patients who meet standardized discharge criteria following minimally-invasive gastrectomy.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether a structured recovery program called ERAS (Enhanced Recovery After Surgery) helps people recover faster and feel better after minimally invasive stomach cancer surgery (laparoscopic or robotic gastrectomy). **You may be eligible if...** - You are 19 years or older - You are scheduled for planned (elective) laparoscopic or robotic stomach removal surgery for gastric cancer - You have been assessed as a reasonably good surgical candidate (ASA class I–III) - You are able to complete questionnaires about your recovery **You may NOT be eligible if...** - Your surgery requires removal of organs other than the stomach (except gallbladder) - You have had prior upper abdominal surgery (except gallbladder removal) - You are allergic to fentanyl, ropivacaine, acetaminophen, or anti-inflammatory drugs Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREERAS protocol

The ERAS protocol includes pre-admission patient education through audiovisual materials; reduction of perioperative fasting duration with preoperative carbohydrate loading and early postoperative oral intake; multimodal prophylaxis for postoperative nausea and vomiting; early removal of surgical drains and intravenous lines; early mobilization; and multimodal analgesia aimed at minimizing postoperative opioid use. The detailed protocol used in this study has been published previously \[https://doi.org/10.5230/jgc.2025.25.e27\].


Locations(10)

Pusan National University Hospital

Busan, South Korea

Dongsan Hospital, Keimyung University School of Medicine

Daegu, South Korea

Chungnam National University Hospital

Daejeon, South Korea

National Cancer Center

Goyang, South Korea

Seoul National University Bundang Hospital

Seongnam, South Korea

Seoul National University Hospital

Seoul, South Korea

Seoul St. Mary's Hospital

Seoul, South Korea

Severance hospital

Seoul, South Korea

SMG-SNU Boramae Medical Center,

Seoul, South Korea

Ajou University School of Medicine

Suwon, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06984952


Related Trials